{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:49:26Z","timestamp":1779356966057,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017332","name":"Rafsanjan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10787-023-01289-8","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T04:01:36Z","timestamp":1689393696000},"page":"3021-3028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators"],"prefix":"10.1007","volume":"31","author":[{"given":"Zahra","family":"Bagheri\u2011Hosseinabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-8549","authenticated-orcid":false,"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"1","key":"1289_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12865-020-00388-3","volume":"21","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Kamiab Z, Hasani M, Rahnama A, Saeed-Askari P, Khorramdelazad H (2020) Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells. BMC Immunol 21(1):58","journal-title":"BMC Immunol"},{"issue":"7","key":"1289_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3899\/jrheum.200755","volume":"48","author":"J Bachiller-Corral","year":"2021","unstructured":"Bachiller-Corral J, Boteanu A, Garcia-Villanueva MJ, de la Puente C, Revenga M, Diaz-Miguel MC, Rodriguez-Garcia A, Morell-Hita JL, Valero M, Larena C, Blazquez-Ca\u00f1amero M, Guillen-Astete CA, Garrote S, Sobrino C, Medina-Qui\u00f1ones C, Vazquez-Diaz M (2021) Risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases. J Rheumatol 48(7):1098\u20131102","journal-title":"J Rheumatol"},{"issue":"1","key":"1289_CR3","first-page":"65","volume":"18","author":"Z Bagheri-Hosseinabadi","year":"2021","unstructured":"Bagheri-Hosseinabadi Z, Ostad Ebrahim H, Bahrehmand F, Taghipour G, Abbasifard M (2021) The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran J Immunol 18(1):65\u201373","journal-title":"Iran J Immunol"},{"issue":"1","key":"1289_CR4","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1038\/s41598-021-82721-3","volume":"11","author":"M Bahardoust","year":"2021","unstructured":"Bahardoust M, Heiat M, Khodabandeh M, Karbasi A, Bagheri-Hosseinabadi Z, Ataee MH, Seidalian N, Babazadeh A, Agah S, Abyazi MA (2021) Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran. Sci Rep 11(1):3066","journal-title":"Sci Rep"},{"issue":"6","key":"1289_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","volume":"383","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 383(6):517\u2013525","journal-title":"N Engl J Med"},{"issue":"8","key":"1289_CR6","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/ard.2010.148619","volume":"70","author":"K Britsemmer","year":"2011","unstructured":"Britsemmer K, Ursum J, Gerritsen M, van Tuyl L, van Schaardenburg D (2011) Validation of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis 70(8):1468\u20131470","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"1289_CR7","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LC, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T (2020) Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Engl J Med 383(21):2041\u20132052","journal-title":"N Engl J Med"},{"issue":"6","key":"1289_CR8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/art.41619","volume":"73","author":"KM D\u2019Silva","year":"2021","unstructured":"D\u2019Silva KM, Jorge A, Cohen A, McCormick N, Zhang Y, Wallace ZS, Choi HK (2021) COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol 73(6):914\u2013920","journal-title":"Arthritis Rheumatol"},{"key":"1289_CR9","doi-asserted-by":"publisher","first-page":"107082","DOI":"10.1016\/j.intimp.2020.107082","volume":"89","author":"N Ebrahimi","year":"2020","unstructured":"Ebrahimi N, Aslani S, Babaie F, Hemmatzadeh M, Hosseinzadeh R, Joneidi Z, Tourzani ZM, Pakravan N, Mohammadi H (2020) Recent findings on the coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics. Int Immunopharmacol 89:107082","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1289_CR10","doi-asserted-by":"publisher","first-page":"2002808","DOI":"10.1183\/13993003.02808-2020","volume":"56","author":"M Edalatifard","year":"2020","unstructured":"Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, Najafizadeh SR, Farhadi E, Jalili N, Esfahani M, Rahimi B, Kazemzadeh H, Mahmoodi Aliabadi M, Ghazanfari T, Sattarian M, Ebrahimi Louyeh H, Raeeskarami SR, Jamalimoghadamsiahkali S, Khajavirad N, Mahmoudi M, Rostamian A (2020) Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J 56(6):2002808","journal-title":"Eur Respir J"},{"issue":"2","key":"1289_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bj.2020.06.010","volume":"44","author":"MI Edilova","year":"2021","unstructured":"Edilova MI, Akram A, Abdul-Sater AA (2021) Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed J 44(2):172\u2013182","journal-title":"Biomed J"},{"issue":"18","key":"1289_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","volume":"382","author":"B Gates","year":"2020","unstructured":"Gates B (2020) Responding to Covid-19\u2014a once-in-a-century pandemic? N Engl J Med 382(18):1677\u20131679","journal-title":"N Engl J Med"},{"issue":"3","key":"1289_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/art.41567","volume":"73","author":"MA Gianfrancesco","year":"2021","unstructured":"Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P (2021) Association of race and ethnicity with COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician registry. Arthritis & Rheumatology 73(3):374\u2013380","journal-title":"Arthritis & Rheumatology"},{"issue":"3","key":"1289_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4049\/jimmunol.1402513","volume":"194","author":"S Han","year":"2015","unstructured":"Han S, Mallampalli RK (2015) The acute respiratory distress syndrome: from mechanism to translation. J Immunol 194(3):855\u2013860","journal-title":"J Immunol"},{"issue":"3","key":"1289_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/BOR.0000000000000598","volume":"31","author":"M Jani","year":"2019","unstructured":"Jani M, Barton A, Hyrich K (2019) Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification? Curr Opin Rheumatol 31(3):285","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1289_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology 52(1):53\u201361","journal-title":"Rheumatology"},{"key":"1289_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119034","volume":"269","author":"F Moadab","year":"2021","unstructured":"Moadab F, Khorramdelazad H, Abbasifard M (2021) Role of CCL2\/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches. Life Sci 269:119034","journal-title":"Life Sci"},{"key":"1289_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108076","volume":"100","author":"M Mohammadhosayni","year":"2021","unstructured":"Mohammadhosayni M, Mohammadi FS, Ezzatifar F, Gorabi AM, Khosrojerdi A, Aslani S, Hemmatzadeh M, Yazdani S, Arabi M, Marofi F (2021) Matrix metalloproteinases are involved in the development of neurological complications in patients with coronavirus disease 2019. Int Immunopharmacol 100:108076","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1289_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.41469","volume":"73","author":"M Putman","year":"2021","unstructured":"Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-Garc\u00eda A (2021) Antirheumatic disease therapies for the treatment of COVID-19: a systematic review and meta-analysis. Arthritis Rheumatol (hoboken, NJ) 73(1):36\u201347","journal-title":"Arthritis Rheumatol (hoboken, NJ)"},{"issue":"1","key":"1289_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.autrev.2017.11.005","volume":"17","author":"A Rubbert-Roth","year":"2018","unstructured":"Rubbert-Roth A, Atzeni F, Masala IF, Caporali R, Montecucco C, Sarzi-Puttini P (2018) TNF inhibitors in rheumatoid arthritis and spondyloarthritis: are they the same? Autoimmun Rev 17(1):24\u201328","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1289_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/berh.2001.0187","volume":"15","author":"H Schulze-Koops","year":"2001","unstructured":"Schulze-Koops H, Kalden JR (2001) The balance of Th1\/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 15(5):677\u2013691","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"24","key":"1289_CR22","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","volume":"383","author":"JH Stone","year":"2020","unstructured":"Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM (2020) Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med 383(24):2333\u20132344","journal-title":"N Engl J Med"},{"issue":"7","key":"1289_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","volume":"80","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld A, Sch\u00e4fer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 80(7):930\u2013942","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1289_CR24","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1002\/jcp.30233","volume":"236","author":"S Tahmasebi","year":"2021","unstructured":"Tahmasebi S, El-Esawi MA, Mahmoud ZH, Timoshin A, Valizadeh H, Roshangar L, Varshoch M, Vaez A, Aslani S, Navashenaq JG (2021) Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. J Cell Physiol 236(7):5325\u20135338","journal-title":"J Cell Physiol"},{"issue":"7","key":"1289_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","volume":"19","author":"P Toniati","year":"2020","unstructured":"Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, Franceschini F, Air\u00f2 P, Bazzani C, Beindorf E-A (2020) Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev 19(7):102568","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1289_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","volume":"25","author":"AJ Turner","year":"2004","unstructured":"Turner AJ, Hiscox JA, Hooper NM (2004) ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 25(6):291\u2013294","journal-title":"Trends Pharmacol Sci"},{"key":"1289_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107088","volume":"89","author":"H Valizadeh","year":"2020","unstructured":"Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Gencer MZ, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M (2020) Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 89:107088","journal-title":"Int Immunopharmacol"},{"key":"1289_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biopha.2018.05.097","volume":"105","author":"N Vanaki","year":"2018","unstructured":"Vanaki N, Aslani S, Jamshidi A, Mahmoudi M (2018) Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother 105:130\u2013143","journal-title":"Biomed Pharmacother"},{"issue":"7821","key":"1289_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821):430\u2013436","journal-title":"Nature"},{"issue":"13","key":"1289_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239\u20131242","journal-title":"JAMA"},{"issue":"6","key":"1289_CR31","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/JLB.4RU0619-197R","volume":"106","author":"P Yang","year":"2019","unstructured":"Yang P, Qian FY, Zhang MF, Xu AL, Wang X, Jiang BP, Zhou LL (2019) Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J Leukoc Biol 106(6):1233\u20131240","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1289_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y (2020) COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther 5(1):1\u20138","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"1289_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells7100161","volume":"7","author":"H-Y Yap","year":"2018","unstructured":"Yap H-Y, Tee SZ-Y, Wong MM-T, Chow S-K, Peh S-C, Teow S-Y (2018) Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells 7(10):161","journal-title":"Cells"},{"issue":"7798","key":"1289_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01289-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T02:06:21Z","timestamp":1701482781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01289-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01289-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Rafsanjan University of Medical Sciences (IR.RUMS.REC.1401.187).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All individuals voluntarily signed a written informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}